Infinity Pharmaceuticals Inc (INFIQ)
0.00
USD |
OTCM |
May 17, 16:00
Infinity Pharmaceuticals Revenue (Quarterly): 0.583M for June 30, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.583M |
| March 31, 2023 | 0.731M |
| December 31, 2022 | 0.543M |
| September 30, 2022 | 0.712M |
| June 30, 2022 | 0.686M |
| March 31, 2022 | 0.652M |
| December 31, 2021 | 0.451M |
| September 30, 2021 | 0.428M |
| June 30, 2021 | 0.512M |
| March 31, 2021 | 0.467M |
| December 31, 2020 | 0.436M |
| September 30, 2020 | 0.496M |
| June 30, 2020 | 0.36M |
| March 31, 2020 | 0.428M |
| December 31, 2019 | 0.308M |
| September 30, 2019 | 0.343M |
| June 30, 2019 | 0.257M |
| March 31, 2019 | 2.142M |
| December 31, 2018 | 0.146M |
| September 30, 2018 | 22.00M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | 6.00M |
| June 30, 2017 |
| Date | Value |
|---|---|
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | 9.467M |
| March 31, 2016 | 9.256M |
| December 31, 2015 | 9.079M |
| September 30, 2015 | 90.74M |
| June 30, 2015 | 4.88M |
| March 31, 2015 | 4.363M |
| December 31, 2014 | 4.356M |
| September 30, 2014 | 160.64M |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | 21.91M |
| March 31, 2012 | 25.20M |
| December 31, 2011 | 22.32M |
| September 30, 2011 | 23.30M |
| June 30, 2011 | 19.96M |
| March 31, 2011 | 27.19M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.257M
Minimum
Jun 2019
0.731M
Maximum
Mar 2023
0.4937M
Average
0.467M
Median
Mar 2021
Revenue (Quarterly) Benchmarks
| Athersys Inc | -- |
| Merck & Co Inc | 15.78B |
| MEI Pharma Inc | -- |
| Humanigen Inc | 0.221M |
| Bristol-Myers Squibb Co | 11.86B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.956M |
| Total Expenses (Quarterly) | 10.70M |
| EPS Diluted (Quarterly) | -0.11 |
| Gross Profit Margin (Quarterly) | 39.62% |
| Profit Margin (Quarterly) | -1.71K% |